Generation Bio Valuation
| GBIO Stock | USD 0.81 0.02 2.41% |
Today, the firm appears to be fairly valued. Generation Bio retains a regular Real Value of $0.78 per share. The prevalent price of the firm is $0.81. Our model calculates the value of Generation Bio from evaluating the firm fundamentals such as Shares Outstanding of 66.79 M, return on equity of -0.86, and Return On Asset of -0.19 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Generation Bio's valuation include:
Price Book 0.5321 | Enterprise Value | Enterprise Value Ebitda (0.34) | Price Sales 2.8961 | Enterprise Value Revenue 5.103 |
Fairly Valued
Today
Please note that Generation Bio's price fluctuation is abnormally volatile at this time. Calculation of the real value of Generation Bio is based on 3 months time horizon. Increasing Generation Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Generation Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Generation Stock. However, Generation Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.81 | Real 0.78 | Target 7.0 | Hype 0.81 | Naive 0.67 |
The intrinsic value of Generation Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Generation Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Generation Bio Co helps investors to forecast how Generation stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Generation Bio more accurately as focusing exclusively on Generation Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Generation Bio's intrinsic value based on its ongoing forecasts of Generation Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Generation Bio's closest peers.
Generation Bio Cash |
|
Generation Valuation Trend
Knowing Generation Bio's actual value is paramount for traders when making sound investment determinations. Using both Generation Bio's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Generation Bio Total Value Analysis
Generation Bio Co is currently forecasted to have valuation of (35.41 M) with market capitalization of 53.81 M, debt of 97.89 M, and cash on hands of 301.17 M. The negative valuation of Generation Bio may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Generation Bio fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(35.41 M) | 53.81 M | 97.89 M | 301.17 M |
Generation Bio Investor Information
About 14.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.53. Some equities with similar Price to Book (P/B) outperform the market in the long run. Generation Bio recorded a loss per share of 2.19. The entity had not issued any dividends in recent years. Based on the analysis of Generation Bio's profitability, liquidity, and operating efficiency, Generation Bio Co may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Generation Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Generation Bio has an asset utilization ratio of 1.58 percent. This suggests that the Company is making $0.0158 for each dollar of assets. An increasing asset utilization means that Generation Bio Co is more efficient with each dollar of assets it utilizes for everyday operations.Generation Bio Ownership Allocation
Generation Bio Co has a total of 66.79 Million outstanding shares. The majority of Generation Bio outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Generation Bio to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Generation Bio Co. Please pay attention to any change in the institutional holdings of Generation Bio as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Generation Bio Profitability Analysis
The company reported the previous year's revenue of 5.9 M. Net Loss for the year was (126.61 M) with loss before overhead, payroll, taxes, and interest of (41.44 M).About Generation Bio Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Generation Bio Co. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Generation Bio based exclusively on its fundamental and basic technical indicators. By analyzing Generation Bio's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Generation Bio's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Generation Bio. We calculate exposure to Generation Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Generation Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -66.5 M | -63.2 M | |
| Pretax Profit Margin | (19.30) | (20.27) | |
| Operating Profit Margin | (21.12) | (22.18) | |
| Net Loss | (19.30) | (20.27) | |
| Gross Profit Margin | (11.27) | (11.83) |
Generation Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 64.5 M |
Generation Bio Current Valuation Indicators
Generation Bio's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Generation Bio's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Generation Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Generation Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Generation Bio's worth.When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share | Quarterly Revenue Growth 2.52 | Return On Assets | Return On Equity |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.